Fully vaccinated with breakthrough infection can transmit COVID-19
Nov 01, 2021
The peak viral load was similar for fully vaccinated and unvaccinated index cases; the viral load declines at faster rate among fully vaccinated individuals.
Adverse events associated with BNT162b2 vaccination ID’d
Aug 27, 2021
Vaccination with the Pfizer–BioNTech mRNA vaccine against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is associated with an increased risk for myocarditis and lymphadenopathy, according...
AAN updates guideline for treatment of painful diabetic neuropathy
Dec 30, 2021
When patients do not experience meaningful improvement with the initial therapeutic class, medication from a different class should be offered.
Higher dose of steroid does not improve outcomes in severe COVID-19
Oct 29, 2021
The number of days alive without life support at day 28 did not differ with dexamethasone 12 mg versus 6 mg in those with severe hypoxemia.
Itepekimab bests placebo for moderate-to-severe asthma
Oct 28, 2021
The incidence of events indicating a loss of asthma control was lower with itepekimab monotherapy in a phase 2, proof-of-concept trial.
Reformulated booster shots ready by September, White House says
Jul 29, 2022
The Biden administration is working on contracts for the reformulated booster doses.
Cognitive, functional decline detected before stroke
Jul 07, 2021
Patients with stroke have steeper declines in the 10 years before stroke compared with stroke-free controls.
Risk for progression to severe COVID-19 lower with nirmatrelvir + ritonavir
Mar 01, 2022
Treatment of symptomatic COVID-19 with nirmatrelvir plus ritonavir was linked to an 89% lower risk for progression versus placebo.
SARS-CoV-2 antibody tests should not be used for diagnosis
Feb 01, 2022
A related review shows that recent infection protected against symptomatic reinfection with the wild-type or alpha variant of SARS-CoV-2.
Remdesivir offers some benefit for hospitalized COVID-19 patients
Feb 01, 2022
No difference was seen for in-hospital mortality, but a need for initiation of mechanical ventilation was reduced with the addition of remdesivir to standard care.